Notification of Implementation – Medicinal Products

Documents from [1994] to [1996]

Identity Statement

HAEU Reference Code
EftaSurv-546
Original Reference Code
GOO211.400.008 – GOO211.400.015
Physical Medium

Paper

Reference Archivists

Carr, Mary

Content and Structure

Abstract

Medicinal products - amending Protocol 47 and certain annexes to the EEA Agreement
Notification of national measures in Norway implementing: Council Directive 92/27/EEC on the labelling of medical products for human use and on package leaflets
Notification of national measures implementing Council Directive 94/62/EC on packaging and packaging waste
Letter of formal notice regarding Council Directive 89/343/EEC (radiopharmaceuticals) and reasoned opinion regarding Council Directive 89/105/EEC (Transparency Directive)
Notification of national measures in Norway on the advertising of medicinal products for human consumption, Council Directive 92/28/EEC
Notification of national measures concerning substances which may be used in the illicit manufacture of narcotic drugs and psychotropic substances from the Norwegian Ministry of Health and Social Affairs
Information on the implementation of acts under the responsibility of the Ministry of Health and Social Affairs
Reasoned opinion of Norwegian Department of Health - substances used in the illicit manufacture of narcotic drugs, Directives 92/109/EEC and 93/46/EEC (Drug precursors)
Notification of national measures implementing directive 91/412/EEC of 23 July 1991 laying down the principles and guidelines of good manufacturing practice for Veterinary Medicinal Products

Conditions of Access and Use

Languages

English, Norwegian

Type of Archival Materials

Textual

Allied Materials

Notes

Notes and Remarks

New case numbers: 18710 - 18716

Icon loader 2acdb8e0a67b493326602c36dfafc6d676b5f427ed73ffa83db703a5365dd0fa
This website requires Javascript to be Activated to work Correctly